Source comparison
TB-500 Research Sleep Latency Considerations: Mechanism Comparison
Beta-Endorphin Elevation Low-dose stimulation delays melatonin onset by inhibiting pineal AANAT enzyme activity 60–150 min post-admin Resolves when tissue repair plateaus (week 4–6) Morning administration (6–9 AM) to avoid evening melatonin conflict Angiogenic
This comparison does not assign a generated winner or score.
- Beta-Endorphin Elevation
- Low-dose stimulation delays melatonin onset by inhibiting pineal AANAT enzyme activity
- 60–150 min post-admin
- Resolves when tissue repair plateaus (week 4–6)
- Morning administration (6–9 AM) to avoid evening melatonin conflict
- Angiogenic Signaling (VEGF, FGF-2)
- Increased nocturnal glucose utilization (8–14% above baseline) diverts energy from circadian maintenance
- 4–6 hours post-admin
- Resolves when VEGF drops below 180 pg/mL
- Pretreatment with magnesium glycinate (400–600 mg) 60 min before sleep
- Actin Remodeling & Mitochondrial Shift
- Altered mitochondrial membrane potential disrupts CLOCK gene amplitude
- Sustained throughout healing phase
- Resolves when MMP-9 activity drops below 300 ng/mL
- Dose timing 12+ hours before intended sleep onset
- Professional Assessment
- TB-500 sleep latency延長 is not a side effect requiring intervention. It's a transient metabolic reallocation toward tissue repair that resolves naturally as healing completes. Administration timing is the highest-leverage mitigation tool available.